N/A
Completed N=98
Validation of WatchBP Office Ankle-brachial Index (ABI) Function
Source: ClinicalTrials.gov NCT01002989 ↗Enrolled (actual)
98
Serious AEs
0.0%
Results posted
Jan 2012
Primary outcomePrimary: Watch BP Office Minus Doppler Ankle-Brachial Index Difference — 0.03 ratio
Summary
Measurement of the ankle-brachial index (ABI) with the oscillometric device WatchBP Office will be assessed compared to the reference method (Doppler).
Ninety three adult subjects assessed for hypertension, treated or untreated, with complete study data were included. Data on the presence of cardiovascular (CV) disease and classical CV risk factors were recorded.
All the ABI measurements of each individual participant will be performed by the same observer in a randomized order (concerning Doppler and WatchBP)
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Watch BP Office Minus Doppler Ankle-Brachial Index Difference |
0.03 | — |
| PRIMARY Mean Doppler Ankle-Brachial Index |
1.08 | — |
| PRIMARY Mean Watch BP Office Ankle-Brachial Index |
1.11 | — |
| SECONDARY Agreement Between the Two Methods in Peripheral Artery Disease (PAD) Diagnosis |
95 | — |
Eligibility Criteria
Inclusion Criteria
- Treated or untreated subjects assessed for hypertension
Exclusion Criteria
- Atrial fibrillation
- Incompressible ankle arteries
Data sourced from ClinicalTrials.gov (NCT01002989). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.